BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30851444)

  • 1. Predictive model of spread of Parkinson's pathology using network diffusion.
    Pandya S; Zeighami Y; Freeze B; Dadar M; Collins DL; Dagher A; Raj A
    Neuroimage; 2019 May; 192():178-194. PubMed ID: 30851444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein: the long distance runner.
    George S; Rey NL; Reichenbach N; Steiner JA; Brundin P
    Brain Pathol; 2013 May; 23(3):350-7. PubMed ID: 23587141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional transcriptional architecture of Parkinson's disease pathogenesis and network spread.
    Freeze B; Pandya S; Zeighami Y; Raj A
    Brain; 2019 Oct; 142(10):3072-3085. PubMed ID: 31359041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
    Halliday G; McCann H; Shepherd C
    Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Lewy pathology propagation in Parkinson's disease.
    Luk KC; Lee VM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S85-7. PubMed ID: 24262196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology of α-synuclein propagation and braak hypothesis.
    McCann H; Cartwright H; Halliday GM
    Mov Disord; 2016 Feb; 31(2):152-60. PubMed ID: 26340605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Parkinson's disease pathology be propagated from one neuron to another?
    Dunning CJ; Reyes JF; Steiner JA; Brundin P
    Prog Neurobiol; 2012 May; 97(2):205-19. PubMed ID: 22115849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prying into the Prion Hypothesis for Parkinson's Disease.
    Brundin P; Melki R
    J Neurosci; 2017 Oct; 37(41):9808-9818. PubMed ID: 29021298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective neuronal vulnerability in Parkinson's disease.
    Gonzalez-Rodriguez P; Zampese E; Surmeier DJ
    Prog Brain Res; 2020; 252():61-89. PubMed ID: 32247375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
    Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prion hypothesis in Parkinson's disease: Braak to the future.
    Visanji NP; Brooks PL; Hazrati LN; Lang AE
    Acta Neuropathol Commun; 2013 May; 1():2. PubMed ID: 24252164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunology of Parkinson's disease.
    Zhu B; Yin D; Zhao H; Zhang L
    Semin Immunopathol; 2022 Sep; 44(5):659-672. PubMed ID: 35674826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concept of alpha-synuclein as a prion-like protein: ten years after.
    Steiner JA; Quansah E; Brundin P
    Cell Tissue Res; 2018 Jul; 373(1):161-173. PubMed ID: 29480459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?
    Kujawska M; Jodynis-Liebert J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
    Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.